ChemMedChem

Cholesterol-based Lipid Nanoparticles for Efficient siRNA Delivery to Solid Tumors

Updated

Abstract

Five ionizable cholesterol derivatives were developed and formulated into lipid nanoparticles (LNPs) for siRNA delivery.

  • The new i-Chol LNPs showed efficient encapsulation and delivery of siRNA in cancer cells.
  • These LNPs exhibited uniform particle size and near-neutral surface charge, which are advantageous for systemic use.
  • Phe-Chol LNPs, loaded with siRNA targeting kinesin spindle protein (KIF11), achieved significant gene knockdown in PC3 prostate cancer cells.
  • Dose-dependent antitumor activity was observed in a xenograft model without any noted systemic toxicity.
  • This approach simplifies the LNP platform while maintaining high delivery efficiency to solid tumors.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free